🔥🔥HF chronicity: 🎯factor for assessment of pts with HF-CS; esp while considering futility/use of #MCS

🏷️Multicenter study with HF-CS pts

👉

@BenediktSchrage @dirkwestermann @thiele_holger @JonaSundermeyer 👏👏
#ACCEarlyCareer #ACCFIT onlinelibrary.wiley.com/doi/10.1002/ej…
‘Conventional’ markers of CS & therapy 🟰 b/w pts with AC HF-CS vs de novo HF-CS

🏷️ Per SCAI classification, CS severity ⬆️ in pts with AC HF-CS, with ⬆️☠️
Long-standing HF in pts with AC HF-CS might -> ⬇️ tolerance to acute haemodynamic decline with #CardiogenicShock

Excellent review for cardiologists to learn #IMV in #CICU in #JACCAdvances @JACCJournals
👉 jacc.org/doi/10.1016/j.…

@andishahu @carlosalviar @seanvandiepen

#JACCEarlyCareer #CardiacCriticalCare 🏷️ Respiratory insufficiency- primary cause for admission to CICU.
🏷️ Liberation from IMV in CICU- needs careful planning and evaluation
🏷️ Research incorporating unique CICU population will better define optimal treatment paradigms

🔥Review on optimal targets in #CardiogenicShock in @JACCJournals #Advances by @benhibbertMDPhD & team 👏
Clinical, biochemical & hemodynamic targets to guide therapy & escalation of therapy.
@Sadeer_AlKindi @baileyannRN #ACCEarlyCareer #ACCFIT
👉jacc.org/doi/10.1016/j.… Current guidelines focus on the t/t of inciting event & restore end-organ perfusion; inotropes/pressors to target MAP ≥65 mm Hg.
🏷 Asses serial markers of systemic perfusion- lactate, ScVO2, UOP, Cr, LFTs, mentation, temp, and invasive hemodynamics & target accordingly